• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes.

作者信息

Kanter Jenny E, Bornfeldt Karin E

机构信息

Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington School of Medicine, Seattle, WA, USA.

Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington School of Medicine, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington Medicine Diabetes Institute, University of Washington School of Medicine, Seattle, WA, USA.

出版信息

J Lipid Res. 2021;62:100010. doi: 10.1194/jlr.ILR120001217. Epub 2020 Dec 13.

DOI:10.1194/jlr.ILR120001217
PMID:33554869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7869003/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1731/7869003/5f8d00b6adfd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1731/7869003/5f8d00b6adfd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1731/7869003/5f8d00b6adfd/gr1.jpg

相似文献

1
Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes.在糖尿病患者的动脉粥样硬化病变中，载脂蛋白C3和载脂蛋白B与巨噬细胞在临近位置共定位。
J Lipid Res. 2021;62:100010. doi: 10.1194/jlr.ILR120001217. Epub 2020 Dec 13.
2
Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.载脂蛋白A-I模拟肽对载脂蛋白E基因敲除小鼠进展期和已形成动脉粥样硬化的不同作用
Circulation. 2004 Sep 21;110(12):1701-5. doi: 10.1161/01.CIR.0000142857.79401.69. Epub 2004 Sep 7.
3
Immunohistochemical localization of apolipoprotein B-100 (ApoB-100) and expression of glutathione peroxidase (GSH-PO) in canine atherosclerotic lesions.载脂蛋白B-100（ApoB-100）在犬动脉粥样硬化病变中的免疫组织化学定位及谷胱甘肽过氧化物酶（GSH-PO）的表达
Vet Pathol. 1998 May;35(3):227-9. doi: 10.1177/030098589803500310.
4
Immunohistochemical double labeling of macrophages, smooth muscle cells, and apolipoprotein E in the atherosclerotic plaque.动脉粥样硬化斑块中巨噬细胞、平滑肌细胞和载脂蛋白E的免疫组织化学双重标记
Pathol Res Pract. 1991 Mar;187(2-3):184-8. doi: 10.1016/S0344-0338(11)80769-7.
5
Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries.载脂蛋白A-I和载脂蛋白A-II在人类动脉粥样硬化动脉中的定位。
Arch Pathol Lab Med. 1989 Jul;113(7):777-80.
6
Association of Ratio of Apolipoprotein B to Apolipoprotein A1 With Survival in Peritoneal Dialysis.载脂蛋白B与载脂蛋白A1的比值与腹膜透析患者生存率的关系
Front Nutr. 2022 Mar 25;9:801979. doi: 10.3389/fnut.2022.801979. eCollection 2022.
7
Evidence that macrophages in atherosclerotic lesions contain angiotensin II.动脉粥样硬化病变中的巨噬细胞含有血管紧张素II的证据。
Circulation. 1998 Aug 25;98(8):800-7. doi: 10.1161/01.cir.98.8.800.
8
Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages.修饰型低密度脂蛋白通过肝 X 受体和 Toll 样受体 4 的激活刺激人巨噬细胞中补体 C3 的表达和分泌。
J Biol Chem. 2012 Feb 17;287(8):5954-68. doi: 10.1074/jbc.M111.289322. Epub 2011 Dec 22.
9
Immunohistochemical detection of apolipoprotein A-I and B-100 in canine atherosclerotic lesions.犬动脉粥样硬化病变中载脂蛋白A-I和B-100的免疫组织化学检测
Vet Pathol. 2003 May;40(3):328-31. doi: 10.1354/vp.40-3-328.
10
Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes.单核细胞和巨噬细胞在糖尿病血管并发症中起主要作用。
Front Cardiovasc Med. 2020 Feb 14;7:10. doi: 10.3389/fcvm.2020.00010. eCollection 2020.

引用本文的文献

1
Hepatic Abnormal Secretion of Apolipoprotein C3 Promotes Inflammation in Aortic Dissection.载脂蛋白C3的肝脏异常分泌促进主动脉夹层炎症。
J Am Heart Assoc. 2025 Feb 4;14(3):e037172. doi: 10.1161/JAHA.124.037172. Epub 2025 Jan 23.
2
Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease.心血管代谢疾病中极低密度脂蛋白产生的分子调控与治疗靶点
Cell Mol Gastroenterol Hepatol. 2025;19(1):101409. doi: 10.1016/j.jcmgh.2024.101409. Epub 2024 Oct 12.
3
Apolipoprotein C3: form begets function.载脂蛋白C3：形态决定功能。
J Lipid Res. 2024 Jan;65(1):100475. doi: 10.1016/j.jlr.2023.100475. Epub 2023 Nov 14.
4
Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis.糖尿病加速动脉粥样硬化中的单核细胞和巨噬细胞泡沫细胞。
Front Cardiovasc Med. 2023 Jun 12;10:1213177. doi: 10.3389/fcvm.2023.1213177. eCollection 2023.
5
Quartet of APOCs and the Different Roles They Play in Diabetes.载脂蛋白 C 四员大将及其在糖尿病中的不同角色
Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1124-1133. doi: 10.1161/ATVBAHA.122.318290. Epub 2023 May 25.
6
The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease.糖尿病相关心血管疾病的残余脂蛋白假说。
Arterioscler Thromb Vasc Biol. 2022 Jul;42(7):819-830. doi: 10.1161/ATVBAHA.122.317163. Epub 2022 May 26.
7
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk.载脂蛋白 C-III 降低可降低心血管风险高危的中度高甘油三酯血症患者风险。
Eur Heart J. 2022 Apr 6;43(14):1401-1412. doi: 10.1093/eurheartj/ehab820.
8
Cardiovascular disease in diabetes, beyond glucose.糖尿病与心血管疾病：不止于血糖。
Cell Metab. 2021 Aug 3;33(8):1519-1545. doi: 10.1016/j.cmet.2021.07.001. Epub 2021 Jul 21.